Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HYPERION THERAPEUTICS INC (HPTX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-15 | Dec-31-14 | Sep-30-14 | Jun-30-14 | Mar-31-14 | Dec-31-13 | Sep-30-13 | Jun-30-13 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 12.3% | 23.2% | 11.6% | 12.1% | 12.2% | 23.8% | 19.4% | 12.0% |
| Gross profit | 87.7% | 76.8% | 88.4% | 87.9% | 87.8% | 76.2% | 80.6% | 88.0% |
| Selling, general and administrative | 48.0% | 76.5% | 50.9% | 30.6% | 57.3% | 85.9% | 55.4% | 126.2% |
| Research and development | 21.8% | 125.3% | 26.8% | 10.9% | 16.5% | 84.9% | 15.9% | 35.1% |
| EBITDA | 18.3% | 69.7% | 11.2% | 47.5% | 14.5% | 34.4% | 9.5% | -72.8% |
| Depreciation | 0.4% | 1.1% | 0.5% | 0.2% | 0.5% | 0.9% | 0.2% | 0.4% |
| EBITA | 17.9% | 68.7% | 10.7% | 47.2% | 13.9% | 33.5% | 9.3% | -73.3% |
| Amortization of intangibles | 2.9% | 28.0% | 5.5% | 5.5% | 5.2% | 26.0% | 6.4% | 4.5% |
| EBIT | 15.0% | 40.7% | 5.2% | 41.8% | 8.7% | 7.5% | 2.9% | -77.8% |
| Pre-tax income | 28.1% | 38.7% | -113.6% | 41.4% | 6.9% | 4.4% | 0.7% | 342.5% |
| Income taxes | 5.0% | -4.3% | 11.6% | -5.7% | 0.5% | 0.4% | 0.0% | 0.0% |
| Net income | 23.1% | 42.9% | -125.2% | 47.1% | 6.5% | 4.0% | 0.7% | 342.5% |
|